Journal article
A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score
Abstract
BACKGROUND: Several biomarkers have been shown to improve risk stratification in patients with non-ST-segment elevation acute coronary syndrome (NSTEACS); however, they have not been integrated into risk prediction tools.
METHODS: C-reactive-protein, N-terminal-pro-brain natriuretic peptide (NT-proBNP), and haemoglobin A1C were measured in 6447 patients with NSTEACS who were enrolled in the Clopidogrel in Unstable Angina to Prevent Recurrent …
Authors
Mehta SR; Eikelboom JW; Rao-Melacini P; Weitz JI; Anand SS; Pare G; Budaj A; Pogue J; Fox KAA; Yusuf S
Journal
Canadian Journal of Cardiology, Vol. 32, No. 11, pp. 1332–1339
Publisher
Elsevier
Publication Date
11 2016
DOI
10.1016/j.cjca.2016.01.029
ISSN
0828-282X